In a filing, Harpoon Therapeutics Inc. revealed its Director HUNT RONALD acquired Company’s shares for reported $10000.0 on Mar 23. In the deal valued at $1.00 per share,10,000 shares were bought. As a result of this transaction, HUNT RONALD now holds 10,000 shares worth roughly $ 8900.0.
PT values the company’s stock at a premium of 94.44 to its Friday closing price.
Price Performance Review of HARP
On Friday, Harpoon Therapeutics Inc. [NASDAQ:HARP] saw its stock fall -14.06% to $0.89. On the same session, the stock had its day’s lowest price of $0.85, but rose to a high of $1.07. Over the last five days, the stock has gained 6.53%. Harpoon Therapeutics Inc. shares have risen nearly 23.16% since the year began. Nevertheless, the stocks have fallen -46.16% over the past one year. While a 52-week high of $3.35 was reached on 02/07/23, a 52-week low of $0.54 was recorded on 05/01/23. SMA at 50 days reached $0.8013, while 200 days put it at $0.7752. A total of 0.48 million shares were traded, compared to the trading of 0.13 million shares in the previous session.
Levels Of Support And Resistance For HARP Stock
The 24-hour chart illustrates a support level at 0.8059, which if violated will result in even more drops to 0.7179. On the upside, there is a resistance level at 1.0259. A further resistance level may holdings at 1.1579. The Relative Strength Index (RSI) on the 14-day chart is 54.08, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.1336, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 56.55%. Stochastics %K at 69.48% indicates the stock is a holding.
How much short interest is there in Harpoon Therapeutics Inc.?
A steep rise in short interest was recorded in Harpoon Therapeutics Inc. stocks on Aug 14, 2023, dropping by 32120.0 shares to a total of 0.1 million shares. Yahoo Finance data shows the prior-month short interest on Jul 13, 2023 was 0.13 million shares. There was a decline of -31.47%, which implies that there is a negative sentiment for the stock. In spite of short shares comprising just 0.38% of the overall stock float, the days-to-cover ratio (short ratio) fell to 0.65.
According to FactSet, Harpoon Therapeutics Inc.’s share price will average $5.33 in the next year, based on opinions of analysts polled by the firm. This is up nearly 404.81 percent from its previous closing price of $1.04. Analysts expect Harpoon Therapeutics Inc. stock to reach the higher price of $8.00, while the lowest price estimate is $1.50. However, 6 analysts have rated HARP stock as a Buy in their predictions for 2023.